Campbell & Co Investment Adviser’s BeOne Medicines Ltd ONC Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,774	Closed	-$1.57M	–	1530
2025 Q1	$1.57M	Buy	+5,774	New	+$1.35M	0.12%	262
2024 Q4	–	Sell	-4,238	Closed	-$951K	–	1430
2024 Q3	$951K	Buy	+4,238	New	+$762K	0.07%	459
2024 Q1	–	Sell	-7,313	Closed	-$1.32M	–	1414
2023 Q4	$1.32M	Buy	+7,313	New	+$1.32M	0.12%	264
2023 Q3	–	Sell	-5,850	Closed	-$1.04M	–	1228
2023 Q2	$1.04M	Buy	+5,850	New	+$1.35M	0.19%	137
2021 Q4	–	Sell	-1,400	Closed	-$508K	–	856
2021 Q3	$508K	Buy	+1,400	New	+$458K	0.17%	211

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Campbell & Co Investment Adviser's ONC Position: Q2 2025 in Review

Campbell & Co Investment Adviser sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 5,774 shares — an estimated $1.57M sold.

Campbell & Co Investment Adviser first reported a position in ONC in Q3 2021 and held it in 5 quarters. The position peaked at $1.57M in Q1 2025. 243 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

Campbell & Co Investment Adviser reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 5,774 BeOne Medicines Ltd shares in Q2 2025, an estimated $1.57M.
Campbell & Co Investment Adviser first reported a position in BeOne Medicines Ltd in Q3 2021 and held it in 5 quarters.
Campbell & Co Investment Adviser's BeOne Medicines Ltd position peaked at $1.57M in Q1 2025.
243 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2025, filed 7 Aug 2025.